Leucine-rich α-2 glycoprotein is an innovative biomarker for psoriasis.
Department of Dermatology, Kochi Medical School, Kochi University, Okohcho, Nankoku, 783-8505, Japan. Electronic address: nakajima@kochi-u.ac.jp.
Hideki
H
Nakajima
Laboratory of Immune Signal, National Institute of Biomedical Innovation, Ibaraki, Japan.
Satoshi
S
Serada
Laboratory of Immune Signal, National Institute of Biomedical Innovation, Ibaraki, Japan.
Minoru
M
Fujimoto
Integrated Center for Advanced Medical Technologies, Kochi Medical School, Kochi University, Okohcho, Nankoku, Japan.
Tetsuji
T
Naka
Department of Dermatology, Kochi Medical School, Kochi University, Okohcho, Nankoku, Japan.
Shigetoshi
S
Sano
D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D002097:C-Reactive Protein / Q000032:analysis; D016022:Case-Control Studies; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004797:Enzyme-Linked Immunosorbent Assay; D006023:Glycoproteins / Q000097:blood*; D064368:Healthy Volunteers; D006801:Humans; D011565:Psoriasis / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D012720:Severity of Illness Index; D012867:Skin / Q000473:pathology; D016896:Treatment Outcome
D015415:Biomarkers; D003879:Dermatologic Agents; D006023:Glycoproteins; C015246:LRG1 protein, human; D002097:C-Reactive Protein